Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?
Chia Hao Chang, Chih Hsin Lee, Jann Yuan Wang
研究成果: 雜誌貢獻 › 快報 › 同行評審
5
引文
斯高帕斯(Scopus)